Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
28 September 2022 - 9:01PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
September
2022
Commission
File Number: 001-38723
Tiziana
Life Sciences LTD
(Exact
Name of Registrant as Specified in Its Charter)
9th Floor
107
Cheapside
London
EC2V
6DN
(Address
of registrant’s principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION
CONTAINED IN THIS REPORT ON FORM 6-K
On
September 28, 2022, Tiziana Life Sciences LTD (the “Company”) issued a news service announcing presentations on intranasal
foralumab at the “Preserving the Brain” Scientific Conference and Exhibit at the Fondazione Prada in Milan.
The
Announcement is furnished herewith as Exhibit 99.1 to this Report on Form 6-K. The information in the attached Exhibit 99.1 is being
furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, or
otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company
under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, except as otherwise set forth herein or as shall
be expressly set forth by specific reference in such a filing.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
TIZIANA
LIFE SCIENCES LTD |
|
|
|
|
Date:
September 28, 2022 |
By: |
/s/
Keeren Shah |
|
|
Name: |
Keeren
Shah |
|
|
Title: |
Finance
Director |
EXHIBIT
INDEX
3
Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
From Oct 2023 to Oct 2024